Although there was no association between EXOSC4 alteration and clinical outcomes of the eight cancer types other than pancreatic cancer (Figure 2 and Figure S2A,B and Tables S8 and S9). This evidence concerns the gene EXOSC4 and pancreatic neoplasm.